Alterity Therapeutics (PRNAD) Change in Working Capital (2010 - 2020)

Alterity Therapeutics (PRNAD) has reported Change in Working Capital for 7 consecutive years, with -$6.6 million the latest figure, recorded in Q2 2020.

• In Q2 2020, Change in Working Capital rose 23.71% year-over-year to -$6.6 million; the TTM figure through Jun 2020 stood at -$8.3 million (down 216.08% YoY), while the FY2024 annual figure was -$12602.8 billion, down 36.58% from the prior year.
• Change in Working Capital came in at -$6.6 million for Q2 2020 at Alterity Therapeutics, down from $1.8 million in the prior quarter.
• The five-year high for Change in Working Capital was $5.2 million in Q4 2018, with the low at -$8.6 million in Q2 2019.
• Average Change in Working Capital over 5 years is -$2.0 million, with a median of -$62574.7 recorded in 2018.
• Across the five-year window, Change in Working Capital soared 474.49% in 2018 and plunged 13711.19% in 2019, its largest moves.
• Year by year, Change in Working Capital stood at $465813.1 in 2016, then surged by 93.6% to $901823.1 in 2017, then surged by 474.49% to $5.2 million in 2018, then plunged by 65.9% to $1.8 million in 2019, then sank by 473.25% to -$6.6 million in 2020.
• According to Business Quant data, Change in Working Capital over the past three periods registered -$6.6 million, $1.8 million, and -$8.6 million for Q2 2020, Q4 2019, and Q2 2019 respectively.